Schroder Investment Management Group Sells 56,468 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Schroder Investment Management Group cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,003,762 shares of the healthcare conglomerate’s stock after selling 56,468 shares during the quarter. UnitedHealth Group makes up 1.0% of Schroder Investment Management Group’s portfolio, making the stock its 15th largest position. Schroder Investment Management Group owned 0.22% of UnitedHealth Group worth $1,013,623,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in UNH. NewSquare Capital LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $25,000. AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter worth $30,000. Promus Capital LLC bought a new position in UnitedHealth Group in the fourth quarter valued at about $32,000. Pillar Financial Advisors LLC bought a new stake in UnitedHealth Group during the 4th quarter worth about $40,000. Finally, DecisionPoint Financial LLC grew its position in shares of UnitedHealth Group by 155.0% during the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after buying an additional 62 shares during the period. Institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on UNH shares. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Piper Sandler cut their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. KeyCorp restated an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Twenty research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Stock Performance

Shares of UNH opened at $515.47 on Friday. The firm has a fifty day simple moving average of $508.81 and a 200 day simple moving average of $544.24. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The stock has a market capitalization of $471.51 billion, a price-to-earnings ratio of 33.26, a PEG ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $5.83 earnings per share. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.63%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Insider Activity

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.